Literature DB >> 9697270

Metabolism of prostaglandins in porcine liver transplantation with a graft harvested after 30- and 60-minute warm ischemia.

H Isai1, J Kimura, K Ito, M Tamura, H Kon, H Kamachi, M Takahashi, K Yamashita, T Shimamura, Y Nakajima.   

Abstract

The influence of warm ischemia on the metabolism of prostaglandins was investigated using a pig liver transplantation model employing the temporary portal arterialization technique. Eighteen pigs were divided into three groups according to warm ischemia time: 0 min (group I, n = 6), 30 min (group II, n = 6), and 60 min (group III, n = 6). During portal arterialization, the hepatic venous prostaglandin E2 (PGE2) level in group III (3356.0 +/- 1011.8 pg/ml) was significantly higher than that in group I (831.7 +/- 182.1 pg/ml; P = 0.0285). The hepatic venous PGE2 levels were significantly higher than the arterial counterparts in all groups both at the beginning and during portal arterialization. At 60 min after portal revascularization, the arterial PGE2 level in group III (886.7 +/- 268.0 pg/ml) was significantly higher than that in group I (99.0 +/- 18.6 pg/ml; P = 0.0116) and II (204.2 +/- 65.4 pg/ml; P = 0.0282). Neither thromboxane B2 (TXB2) nor 6-keto PGF1 alpha showed any significant differences. In conclusion, the intraoperative changes of PGE2 thus reflected the degree of warm ischemic damage, and PGE2 could also be released from the graft. On the other hand, the increased levels of TXB2 and 6-keto PGF1 alpha were thought to have an extrahepatic origin.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9697270     DOI: 10.1007/BF02484623

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  12 in total

1.  Changes of thromboxane B2 level in experimental orthotopic liver transplantation in swines--the effect of warm ischemia and thromboxane A2 synthetase inhibition.

Authors:  M Urade; R Izumi; T Iyobe; K Iwasa; H Masutani; T Tani; K Yabushita; T Hashimoto; M Kiriyama; K Shimizu
Journal:  Transplant Proc       Date:  1992-08       Impact factor: 1.066

2.  Prostanoid release in experimental liver transplantation.

Authors:  S Post; M Goerig; G Otto; M Manner; N Senninger; B Kommerell; C Herfarth
Journal:  Transplantation       Date:  1990-03       Impact factor: 4.939

3.  Prostacyclin and thromboxane A2 moderate postischemic renal failure.

Authors:  S Lelcuk; F Alexander; L Kobzik; C R Valeri; D Shepro; H B Hechtman
Journal:  Surgery       Date:  1985-08       Impact factor: 3.982

4.  Rapid increase in the activity of enzymes of eicosanoid synthesis in hepatic and extrahepatic tissues after experimental liver transplantation.

Authors:  S Post; M Goerig; G Otto; M Manner; C Foltis; W Hofmann; C Herfarth
Journal:  Transplantation       Date:  1991-05       Impact factor: 4.939

5.  The protective effect of thromboxane A2 synthetase inhibitor against ischemic liver injury.

Authors:  H Isozaki; K Okajima; H Hara; M Kobayashi
Journal:  Surg Today       Date:  1994       Impact factor: 2.549

6.  Prostacyclin, thromboxane, and oxygen free radicals and postoperative liver function in human liver transplantation.

Authors:  J C García-Valdecasas; R Rull; L Grande; J Fuster; A Rimola; A M Lacy; F X Gonzalez; E Cugat; P Puig-Parellada; J Visa
Journal:  Transplantation       Date:  1995-10-15       Impact factor: 4.939

7.  Hepatoprotection by a PGI2 analogue in complete warm ischemia of the pig liver. Prostanoid release from the reperfused liver.

Authors:  Y I Kim; T Kai; S Kitano; T Ishii; T Tatsuma; N Kamada; K Sugimachi
Journal:  Transplantation       Date:  1994-10-27       Impact factor: 4.939

8.  Cytoprotective effect of prostaglandin I2 on ischemia-induced hepatic cell injury.

Authors:  O Sikujara; M Monden; K Toyoshima; J Okamura; G Kosaki
Journal:  Transplantation       Date:  1983-09       Impact factor: 4.939

9.  Vasodilating prostaglandins attenuate ischemic renal injury only if thromboxane is inhibited.

Authors:  J M Klausner; I S Paterson; L Kobzik; C Rodzen; C R Valeri; D Shepro; H B Hechtman
Journal:  Ann Surg       Date:  1989-02       Impact factor: 12.969

Review 10.  Liver cytoprotection by prostaglandins.

Authors:  J Quiroga; J Prieto
Journal:  Pharmacol Ther       Date:  1993       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.